XML 54 R42.htm IDEA: XBRL DOCUMENT v3.25.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Jul. 07, 2017
Net income (loss)     $ (1,943,000) $ (1,221,000)    
Cash used in operations     577,000 1,453,000    
Cash and cash equivalents $ 490,000   490,000      
Accumulated deficit (56,200,000)   (56,200,000)      
Recognize revenue     309,752   $ 211,724  
Allowance for sales returns     90,540   227,000  
Inventory Reserve 868,000   868,000   1,100,000  
Warranty Reserve 22,648   22,648   $ 30,000  
Advertising And Promotional Expenses 24,000 $ 35,000 88,000 192,000    
Research and Development Expense $ 11,000 $ 56,000 $ 139,000 $ 186,000    
Issued shares of common stock     60,000 60,000    
Cash Balances At Financial Institutions     $ 250,000      
Shares of common stock outstanding 20,075,205   20,075,205   20,015,205  
Common Stock, Shares Authorized 250,000,000   250,000,000   250,000,000  
2016 Equity Incentive Plan            
Shares of common stock outstanding 5,900,000 5,700,000 5,900,000 5,700,000    
Common Stock, Shares Authorized           2,000,000
Warrants            
Potentially Dilutive Securities 2,604,388 2,765,846 2,604,388 2,765,846    
Convertible debentures            
Potentially Dilutive Securities 2,508,000 2,080,000 2,508,000 2,080,000    
Stock Options            
Potentially Dilutive Securities 768,792 805,042 768,792 805,042    
Preferred A stock            
Potentially Dilutive Securities 63,750 63,750 63,750 63,750    
One Vendors | Accounts Payable            
Concentration Risk, Percentage 46.00%   46.00%   60.00%  
Two Vendors | Cost of Sales [Member]            
Concentration Risk, In Percentage 59.00% 53.00% 50.00% 65.00%